K250233

Substantially Equivalent

PreemptiveAI Clinical SDK

Applicant: Measure Labs, Inc. (Dba Preemptiveai, Inc.)
Product code: DXH
Advisory panel: Cardiovascular
Date received: 2025-01-27
Decision date: 2026-02-13
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Seattle, WA, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.